Recombinant Streptomyces actuosus Nosiheptide precursor (nosM)
| Product Name | Recombinant Streptomyces actuosus Nosiheptide precursor (nosM) |
|---|---|
| Description | Inhibits bacterial protein biosynthesis by binding to ribosomes. Specifically, binds to the complex of 23S rRNA and ribosomal protein L11 (RPLK) in the 50S ribosomal subunit. While allowing a weak binding of elongation factor G (EF-G) to the ribosome and subsequent GTP-hydrolysis, probably impairs conformational changes in both the ribosome and EF-G which are necessary for translocation. In vitro, inhibits Gram-positive bacteria S.aureus strain 209P (MIC=0.0009 µg/ml), S.aureus strain 133 (MIC=0.0019 µg/ml), S.aureus strain B3 (MIC=0.003 µg/ml), S.aureus strain Hb (MIC=0.003 µg/ml), M.citreus strain ATCC 8411 (MIC=0.0038 µg/ml), M.lysodeikticus strain ATCC 4698 (MIC=0.003 µg/ml), S.lutea strain ATCC 9341 (MIC=0.0011 µg/ml), S.faecalis strain ATCC 9790 (MIC=0.0007 µg/ml), S.viridans (MIC=0.0065 µg/ml), S.pyogenes hemolyticus strain Dig7 (MIC=0.00028 µg/ml), D.pneumoniae strain Til (MIC=0.00015 µg/ml), N.catrrhalis (MIC=0.0017 µg/ml), L.casei strain ATCC 6633 (MIC=0.003 µg/ml), B.cereus strain ATCC 6630 (MIC=0.0071 µg/ml) and various isolates of L.monocytogenes. In vitro, inhibits Gram-negative bacterium P.multocida strain A125 (MIC=0.0024 µg/ml) but not M.smegmatis strain ATCC 6630, S.typhimurium, A.aerogenes strain ATCC 8308, P.vulgaris, K.pneumoniae strain ATCC 10031, S.marcescens strain A476, P.aeruginosa strain Bass or B.bronchiseptica strain CN387. Does not inhibit Gram-negative bacterium E.coli strain ATCC 9637 but does inhibit purified ribosomes from E.coli. In vivo, has no systemic effect in mice infected with staphylococci or streptococci when applied orally or subcutaneously. Has a local effect in mice infected subcutaneously or intraperitoneally with staphylococci when applied immediately afterwards. Is not toxic to mice. |
| Synonyms |
Antibiotic 9671-RP1 Publication Multhiomycin |
| Host | Yeast |
| Molecular Weight | 32.4 |
| Amino Acid Sequence | MDAAHLSDLDIDALEISEFLDESRLEDSEVVAKVMSASCTTCECCCSCSS |
| Protein Length | Full Length, 1-50aa |
| Tag | N-terminal GST-tagged |
| Reactivity | Bacteria |
| Applications | SDS-PAGE |
| Form | Liquid, in Tris-based buffer, 50% glycerol |
| Purity | Greater than 90% as determined by SDS-PAGE. |
| References |
"Mapping the binding site of thiopeptide antibiotics by proximity-induced covalent capture."Baumann S., Schoof S., Harkal S.D., Arndt H.D. J. Am. Chem. Soc. 130:5664-5666(2008) |
| Background | Inhibits bacterial protein biosynthesis by binding to ribosomes. Specifically, binds to the complex of 23S rRNA and ribosomal protein L11 (RPLK) in the 50S ribosomal subunit. While allowing a weak binding of elongation factor G (EF-G) to the ribosome and subsequent GTP-hydrolysis, probably impairs conformational changes in both the ribosome and EF-G which are necessary for translocation. In vitro, inhibits Gram-positive bacteria S.aureus strain 209P (MIC=0.0009 µg/ml), S.aureus strain 133 (MIC=0.0019 µg/ml), S.aureus strain B3 (MIC=0.003 µg/ml), S.aureus strain Hb (MIC=0.003 µg/ml), M.citreus strain ATCC 8411 (MIC=0.0038 µg/ml), M.lysodeikticus strain ATCC 4698 (MIC=0.003 µg/ml), S.lutea strain ATCC 9341 (MIC=0.0011 µg/ml), S.faecalis strain ATCC 9790 (MIC=0.0007 µg/ml), S.viridans (MIC=0.0065 µg/ml), S.pyogenes hemolyticus strain Dig7 (MIC=0.00028 µg/ml), D.pneumoniae strain Til (MIC=0.00015 µg/ml), N.catrrhalis (MIC=0.0017 µg/ml), L.casei strain ATCC 6633 (MIC=0.003 µg/ml), B.cereus strain ATCC 6630 (MIC=0.0071 µg/ml) and various isolates of L.monocytogenes. In vitro, inhibits Gram-negative bacterium P.multocida strain A125 (MIC=0.0024 µg/ml) but not M.smegmatis strain ATCC 6630, S.typhimurium, A.aerogenes strain ATCC 8308, P.vulgaris, K.pneumoniae strain ATCC 10031, S.marcescens strain A476, P.aeruginosa strain Bass or B.bronchiseptica strain CN387. Does not inhibit Gram-negative bacterium E.coli strain ATCC 9637 but does inhibit purified ribosomes from E.coli. In vivo, has no systemic effect in mice infected with staphylococci or streptococci when applied orally or subcutaneously. Has a local effect in mice infected subcutaneously or intraperitoneally with staphylococci when applied immediately afterwards. Is not toxic to mice. |
| Supplier | Cusabio |
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
